PHARMANUTRA overview

PHARMANUTRA S.P.A PARTNERS WITH FERRARI-AF CORSE TO FACE THE CHALLENGES OF THE NEW LE MANS HYPERCAR 499P PR Newswire PISA, Italy, Feb. 9, 2023 PISA, Italy , Feb. 9, 2023 /PRNewswire/ -- PharmaNutra S.p.A. (MTA: PHN), a company specialised in mineral and iron-based nutritional supplements and medical devices for muscles and joints, is ready to face the great challenge of the FIA World Endurance Championship (WEC) alongside Team Ferrari-AF Corse, which will be competing with two official Ferrari...

PHARMANUTRA S.P.A PARTNERS WITH FERRARI-AF CORSE TO FACE THE CHALLENGES OF THE NEW LE MANS HYPERCAR 499P PR Newswire PISA, Italy, Feb. 9, 2023 PISA, Italy , Feb. 9, 2023 /PRNewswire/ -- PharmaNutra S.p.A. (MTA: PHN), a company specialised in mineral and iron-based nutritional supplements and medical devices for muscles and joints, is ready to face the great challenge of the FIA World Endurance Championship (WEC) alongside Team Ferrari-AF Corse, which will be competing with two official Ferrari...

PHARMANUTRA S.P.A.: NEW DISTRIBUTION AGREEMENTS IN INDONESIA, KUWAIT AND MEXICO PR Newswire PISA, Italy, Jan. 4, 2023 PISA, Italy , Jan. 4, 2023 /PRNewswire/ -- PharmaNutra S.p.A. (MTA: PHN), a company specialised in mineral and iron-based nutritional supplements and medical devices for muscles and joints health, is pleased to announce the signing of three new international trade agreements for the distribution of its SiderAL ® and Cetilar ® lines in the Republic of Indonesia , Kuwait and...

PHARMANUTRA S.P.A.: NEW COMPANY PHARMANUTRA U.S.A. CORP. ESTABLISHED FOR DISTRIBUTION IN THE UNITED STATES PR Newswire PISA, Italy, Dec. 13, 2022 With the establishment of the new company, a wholly-owned subsidiary of PharmaNutra S.p.A., in the course of 2023 the Group will start distributing and marketing its products in the US market. PISA, Italy , Dec. 13, 2022 /PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), a company specialising in iron- and mineral-based nutritional supplements and...

PHARMANUTRA: SIGNING OF THE AGREEMENT FOR THE ACQUISITION OF 100% OF AKERN S.R.L. PR Newswire PISA, Italy, June 15, 2022 PISA, Italy , June 15, 2022 /PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), a company specialized in nutritional supplements, based on iron and minerals and medical devices for muscles and joints, is pleased to announce the signing of the contract for the acquisition from Red Lions S.p.A ., Jacopo Talluri and Liside S.r.l., of the 100% of Akern S.r.l. – growing player...

PHARMANUTRA S.P.A.: NEW LICENCE GRANTED IN THE U.S.A. The US Patent Office has granted the company a patent for use of Cetylated Fatty Acids (CFA), the basic functional ingredient in the Cetilar® product line. PR Newswire PISA, Italy, Jan. 17, 2022 PISA, Italy , Jan. 17, 2022 /PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), a company specialising in mineral- and iron-based nutritional supplements and medical devices for muscles and joints, has been granted a patent in the United States for...

PHARMANUTRA: NEW SCIENTIFIC STUDIES ON SUCROSOMIAL® TECHNOLOGY APPLIED TO IRON PR Newswire PISA, Italy, Dec. 21, 2021 PISA, Italy, Dec. 21, 2021 /PRNewswire/ -- Since 2003, the scientific research activity of PharmaNutra (MTA; Ticket PHN), a group of companies specialized in the development, production and distribution of raw materials (active ingredients) for the pharmaceuticals and nutraceuticals market, has focused on identifying a more effective and safe way to solve the problems related to...

ApportAL®: A Valid Opportunity for All People Suffering From Chronic Fatigue PR Newswire PISA, Italy, Nov. 4, 2021 PISA, Italy , Nov. 4, 2021 /PRNewswire/ -- PharmaNutra is pleased to announce the recent publication of the "Observational study on the benefit of a nutritional supplement, supporting immune function and energy metabolism, on chronic fatigue associated with the SARS-CoV-2 post-infection progress" with as first Author Dr. Maria Sole Rossato of PharmaNutra Scientific Department . The...